Ginkgo's Datapoints Collaborates With Inductive Bio, Tangible Scientific to Make Lab-in-the-Loop Drug Discovery
MT Newswires Live
Aug 20, 2025
Ginkgo Bioworks Holdings (DNA) said Wednesday that its Datapoints offering has signed a collaboration with Inductive Bio and Tangible Scientific to develop artificial intelligence-driven lab-in-the-loop drug discovery.
Financial terms of the partnership were not disclosed.
The partnership will integrate Datapoints' rapid ADME profiling, Inductive's model-driven chemistry design platform, and Tangible's API-enabled compound management platform for experimental results in a single workstream, Ginkgo said.
These services are available now and customized for pharmaceutical and biotech teams, Ginkgo said.
Ginkgo's stock was up 4% in recent Wednesday premarket activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.